论文部分内容阅读
The optimal antisense accessible sites (AAS) of uroplakin Ⅱ (UPⅡ) mRNA, a specific gene expressed in bladder urothelium, were selected in order to provide a novel method for targeted therapy of transitional cell carcinoma (TCC) of bladder. The 20 mer rand